Home / 2019 / October / 01

Daily Archives: October 1, 2019

Powerful Mining Rigs offer extended by BitHarp

WELLINGTON, New Zealand, Oct. 01, 2019 (GLOBE NEWSWIRE) — BitHarp is pleased to announce an extension of its highly successful ‘3 Plus 1 Offer’ for the company’s profitable mining rigs. Introduced just a couple of…

Ethan Allen Launches New Membership Program

Danbury, CT, Oct. 01, 2019 (GLOBE NEWSWIRE) — Ethan Allen, a leading global interior design company and a renowned manufacturer and retailer of quality home furnishings, announced the launch of a new Member Program that…

Sabin Vaccine Institute Receives $20.5 Million From BARDA With Potential of up to $128 Million to Develop Ebola Sudan and Marburg Vaccines

WASHINGTON, Oct. 01, 2019 (GLOBE NEWSWIRE) — The Sabin Vaccine Institute (Sabin) today announced a funding award of $20.5 million with options for an additional $107.5 million from the Biomedical Advanced Research and Development Authority…

Sigma Lithium Announces a Positive Feasibility Study with Forecast LOM Net Revenue of US$1.4 Billion and EBITDA of US$ 690 Million for the High-Grade, Low-Cost Xuxa Deposit

Figure 1 General Site Plan Positive results confirm an after tax NPV of US$ 249 million with cash operating costs for the Xuxa deposit of US$238 per tonne of battery grade 6% lithium oxide concentrate,…

GMAT™ Official Advanced Questions Now Available

Hard questions taken directly from past GMAT exams, expanding candidate test day preparation options RESTON, Va., Oct. 01, 2019 (GLOBE NEWSWIRE) — The Graduate Management Admission Council™ (GMAC™), administrator of the Graduate Management Admission Test™…

Ctrip Chairman Meets with Philippine Secretary of Tourism

Philippines Tourism to Receive Boost from Ctrip Ctrip Chairman Meets with Philippine Secretary of Tourism Ctrip Chairman James Liang (left) meets with Philippines Secretary of Tourism Romulo-Puyat (right) MANILA, Oct. 01, 2019 (GLOBE NEWSWIRE) —…

Third-party evaluation confirms safety profile of Philips Stellarex .035″ low-dose drug-coated balloon

October 1, 2019  Primary safety analysis of Stellarex drug-coated balloon (DCB) three-year data, comprising the largest published, pooled set of randomized controlled trial (RCT) data for a single paclitaxel-based device, shows no difference in mortality…